Next Article in Journal
Structural Identification of Antibacterial Lipids from Amazonian Palm Tree Endophytes through the Molecular Network Approach
Next Article in Special Issue
Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation
Previous Article in Journal
Biomarkers in Pneumonia—Beyond Procalcitonin
Previous Article in Special Issue
Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
Open AccessReview

Inhaled Cisplatin for NSCLC: Facts and Results

1
3rd Department of Surgery, “AHEPA” University Hospital, Aristotle University of Thessaloniki, Medical School, 57001 Thessaloniki, Greece
2
Department of Pharmacology & Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 57001 Thessaloniki, Greece
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(8), 2005; https://doi.org/10.3390/ijms20082005
Received: 25 March 2019 / Revised: 15 April 2019 / Accepted: 18 April 2019 / Published: 24 April 2019
(This article belongs to the Special Issue Cisplatin in Cancer Therapy: Molecular Mechanisms of Action)
Although we have new diagnostic tools for non-small cell lung cancer, diagnosis is still made in advanced stages of the disease. However, novel treatments are being introduced in the market and new ones are being developed. Targeted therapies and immunotherapy have brought about a bloom in the treatment of non-small cell lung cancer. Still we have to find ways to administer drugs in a more efficient and safe method. In the current review, we will focus on the administration of inhaled cisplatin based on published data. View Full-Text
Keywords: cisplatin; lung cancer; inhalation; nebulizers; NSCLC cisplatin; lung cancer; inhalation; nebulizers; NSCLC
Show Figures

Figure 1

MDPI and ACS Style

Kosmidis, C.; Sapalidis, K.; Zarogoulidis, P.; Sardeli, C.; Koulouris, C.; Giannakidis, D.; Pavlidis, E.; Katsaounis, A.; Michalopoulos, N.; Mantalobas, S.; Koimtzis, G.; Alexandrou, V.; Tsiouda, T.; Amaniti, A.; Kesisoglou, I. Inhaled Cisplatin for NSCLC: Facts and Results. Int. J. Mol. Sci. 2019, 20, 2005.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop